Abstract: Slide Presentations |

Utility of Technetium-99m Myocardial Perfusion Imaging After Transmyocardial Laser Revascularization FREE TO VIEW

Vijayendra K. Verma, MD*; Kimberly Parks, DO; Elias A. Iliadis, MD
Author and Funding Information

Cooper Hospital/UMDNJ-Robert Wood Johnson Medical School, Camden, NJ


Chest. 2004;126(4_MeetingAbstracts):710S. doi:10.1378/chest.126.4_MeetingAbstracts.710S
Text Size: A A A
Published online


PURPOSE:  Transmyocardial laser revascularization(TMR) has been used in treating patients with coronary artery disease either as sole treatment or in combination with coronary artery bypass surgery(CABG). Myocardial perfusion imaging(MPI) with thallium-201 has been used for assessment of perfusion post TMR, however Technetium-99m(Tc99m)is currently the standard. No studies have evaluated the use of Tc99m in patients who have received TMR with CABG. We evaluated the utility of Tc99m MPI summed stress scores (SSS) and correlation of clinical symptoms in TMR patients.

METHODS:  97 patients had TMR with CABG from 1998 to 2002. 12 were selected for review based on the availability of post-operative MPI. Studies were reviewed by a nuclear cardiologist and given a SSS based on the standard 17-segment scoring system. Canadian Cardiovascular Society(CCS) angina scores were obtained in all patients pre- and post-operatively, and end points were assessed including myocardial infarction(MI), need for post operative revascularization procedures, and death. These findings were correlated with the Tc99m MPI SSS.

RESULTS:  Patients received MPI on average of 12 months postoperatively. Average age was 59 and an average CCS of 3.6. 64% had hypertension, 36% diabetes, 82% dyslipidemia, 36% had prior MI and 54% tobacco use. Postoperatively, 50% required diagnostic cardiac catheterization, of those only 2 patients required further revascularization. Postoperatively, all patients reported an improvement and 67% had complete resolution of symptoms; an average CCS of 2.6. The overall SSS was 14 and the TMR segments had higher average SSS per segment 3.2 versus the grafted areas with SSS 1.8. No new MIs or deaths occurred.

CONCLUSION:  Tc99m MPI is a useful tool in predicting long term clinical outcomes in CAD patients. However, even with the increased sensitivity of Tc99m, which may identify more subtle abnormalities over previous isotopes, no improvement was found in the TMR segments. Discordance between SSS in the TMR segments and symptom improvement are consistent with prior studies utilizing thallium-201.

CLINICAL IMPLICATIONS:  Symptom improvement may occur with TMR, but Tc99m MPI does not reveal improvement of ischemia.

DISCLOSURE:  V.K. Verma, None.

Monday, October 25, 2004

10:30 AM- 12:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543